The Bombay High Court has penalized the Maharashtra FDA with a ₹5 lakh fine for keeping a Pune-based sweet shop's license suspended despite a 98% compliance report. The court criticized the regulator's actions as "overboard" and "perverse," allowing the shop to reopen immediately.
- The Bombay High Court imposed a ₹5 lakh penalty on the Maharashtra FDA for administrative overreach.
- Pune-based Gurunanak Dairy and Sweets had its license suspended despite achieving 98% compliance in a re-inspection.
- The Division Bench labeled the FDA's persistent suspension policy as "strange and perverse" to business freedom.
The Bombay High Court on Monday (August 17, 2026) directed the Maharashtra Food and Drug Administration (FDA) to pay ₹5 lakh in compensation to a Pune-based sweet shop. The court observed that the regulator kept the shop’s license suspended despite a 98% compliance report, causing significant financial losses. A Division Bench of Acting Chief Justice Ravindra Ghuge and Justice Gautam Ankhad termed the FDA's persistent suspension policy "strange and perverse."
The legal battle began after 'Gurunanak Dairy and Sweets' challenged the FDA's action in the High Court. On June 12, an FDA food safety officer inspected the shop following a food poisoning complaint and suspended its license due to sanitation concerns. Although the shop owners immediately addressed the issues and scored 98% compliance during a July 13 re-inspection, the FDA failed to restore their business license.
FDA Action vs. High Court Verdict
The following table outlines the contrast between the regulatory body's actions and the High Court's judicial intervention:
| Parameter | Maharashtra FDA Action | Bombay High Court Ruling |
|---|---|---|
| Basis of Action | Sanitation complaints and food poisoning | Suspension justified initially, but indefinite closure is illegal |
| Compliance Response | Ignored the 98% compliance re-inspection report | Ordered immediate revocation of suspension post-compliance |
| Financial Redressal | No compensation offered; cited procedural delay | Directed FDA to pay ₹5 lakh compensation within a month |
Why This Matters
BozokMedia analysis shows that this ruling serves as a landmark precedent balancing public health regulation with the ease of doing business in India. While regulatory bodies hold the absolute right to enforce hygiene standards, bureaucratic inertia cannot be used to strangulate local businesses. The court's decision highlights that administrative actions must remain proportional, fair, and swift once compliance is met.
"Regulation must aim at correction, not destruction. Keeping a business shut after 98% compliance is administrative high-handedness that rightfully invited judicial intervention."
Case Background and FDA's Defence
According to the petition, the shop owners suffered a revenue loss of approximately ₹8.74 lakh during the shutdown period starting in June. Despite submitting multiple compliance reports and representations to the FDA Commissioner, no action was taken, forcing them to approach the High Court for relief.
During the hearing, the High Court Bench noted, "We have observed that your intention is laudable... But you are going overboard. You should have immediately revoked the suspension of the license once you noticed 98 per cent compliance." Meanwhile, Maharashtra FDA Commissioner Tukaram Mundhe (IAS) stated that he would examine the detailed court order before responding, adding that the FDA always acts in accordance with the law and prescribed guidelines.
Frequently Asked Questions
Q1: Why did the Bombay High Court fine the Maharashtra FDA?
The court fined the FDA ₹5 lakh for failing to restore a Pune sweet shop's license despite a re-inspection report showing 98% compliance, causing the business severe financial losses.
Q2: What was FDA Commissioner Tukaram Mundhe's response to the ruling?
Commissioner Tukaram Mundhe stated that he would thoroughly examine the High Court's written order before responding, maintaining that the FDA functions strictly according to the law.
